DexCom Announces Upcoming Conference Presentation

SAN DIEGO--()--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:

  • Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Canaccord Genuity Growth Conference in Boston, MA on Wednesday, August 9, 2017 at 12:00pm (ET). The presentation, which will occur live at the Intercontinental Hotel, will be concurrently webcast.

The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Contacts

DexCom, Inc.
Steven R. Pacelli, 858-200-0200
Executive Vice President, Strategy and Corporate Development

Release Summary

DexCom Announces Upcoming Conference Presentation

Contacts

DexCom, Inc.
Steven R. Pacelli, 858-200-0200
Executive Vice President, Strategy and Corporate Development